What happens when I stop taking GLP-1s? Will I regain the weight?

When you stop taking GLP-1 receptor agonists (like Ozempic, Wegovy, Mounjaro, Saxenda, Trulicity, etc.), it's common to regain some of the weight you lost. This is because GLP-1s work in several ways to help with weight loss, and when you stop taking them, those mechanisms are no longer in play.

Here's a breakdown of what typically happens:

• Appetite Regulation: GLP-1s help you feel fuller for longer and can reduce cravings. When you stop, your appetite may increase, and you might find yourself feeling hungrier throughout the day.
• Slowing Gastric Emptying: GLP-1s slow down how quickly your stomach empties. This contributes to feeling full. When you stop, this effect diminishes, and food may move through your digestive system faster.
• Brain Signals: GLP-1s can influence brain areas that control appetite and food reward. Stopping them can lead to a return of these signals, potentially increasing your desire for food, especially high-calorie or palatable foods.

Will you regain the weight?

Yes, it is very likely that you will regain a significant portion of the weight you lost. Studies have shown that for many individuals, stopping GLP-1s leads to a substantial regain of weight, often close to what was initially lost. For example, one prominent study found that participants regained about two-thirds of the weight they had lost after discontinuing Wegovy.

What can you do?

It's crucial to discuss stopping GLP-1s with your doctor. They can help you:

• Understand the implications: Your doctor can explain the likelihood of weight regain based on your individual response to the medication and other factors.
• Develop a plan: To minimize weight regain, your doctor might recommend a gradual tapering off the medication, if appropriate, and focus on intensive lifestyle changes.
• Focus on sustainable lifestyle changes: This is the most critical aspect. To maintain weight loss after stopping GLP-1s, you will likely need to commit to:
  • A healthy, balanced diet: This means focusing on whole foods, lean proteins, fruits, vegetables, and whole grains, and being mindful of portion sizes and calorie intake.
  • Regular physical activity: Aim for a combination of cardiovascular exercise and strength training.
  • Behavioral support: This can include working with a registered dietitian, a therapist specializing in eating behaviors, or joining a weight management program.

Considerations for specific brands:

While the general principles of weight regain apply across all GLP-1s, the duration of action and specific potency can vary slightly. However, the fundamental mechanism of action is similar.

• Semaglutide (Ozempic, Wegovy, Rybelsus): These are very effective for weight loss and appetite suppression. Stopping them is likely to lead to significant weight regain without ongoing lifestyle modifications.
• Liraglutide (Saxenda, Victoza): Saxenda is specifically approved for weight management and works similarly to semaglutide in this regard.
• Tirzepatide (Mounjaro, Zepbound): This is a dual GIP/GLP-1 agonist, and studies have shown it to be very effective for weight loss. Discontinuation is also expected to lead to weight regain.
• Dulaglutide (Trulicity): While primarily used for diabetes, it can have some weight loss effects. Stopping it would likely reverse any modest weight loss.
• Exenatide (Byetta, Bydureon): Similar to other GLP-1s, stopping these can lead to weight regain.

In summary, stopping GLP-1 medications will likely result in weight regain because you lose the pharmacological support for appetite control and metabolism. To mitigate this, a strong emphasis on long-term dietary changes, regular exercise, and potentially behavioral support is essential. Always consult your healthcare provider before making any changes to your medication regimen.